急诊入院时标准碱剩余与热射病患者结局的相关性
这项回顾性、观察性多中心队列研究连续纳入2021至2022年间151例热射病患者,在急诊科入院时检测标准碱剩余(SBE),主要终点为院内死亡。SBE中位数-4.70(-8.05至-1.55)mmol/L,院内总死亡率12.58%;SBE与院内死亡独立相关(OR 0.81,95%CI 0.70-0.95,P=0.011)。年龄和热射病类型对SBE与院内死亡的关系有交互作用,经典热射病者OR 0.5(95%CI 0.3-0.9,P<0.018)、>65岁者OR 0.62(95%CI 0.45-0.87,P=0.005),两组预测院内死亡的AUC分别为0.868(95%CI 0.704-0.962)和0.883(95%CI 0.750-0.951)。SBE还与入住ICU、急性肾衰竭、急性呼吸衰竭、脓毒症和凝血功能障碍显著相关。
要点
- 151例热射病患者急诊入院SBE中位数-4.70(-8.05至-1.55)mmol/L,院内死亡率12.58%。
- SBE与院内死亡独立相关:OR 0.81(95%CI 0.70-0.95,P=0.011)。
- 经典热射病者SBE与院内死亡OR 0.5(95%CI 0.3-0.9,P<0.018),预测AUC 0.868(95%CI 0.704-0.962)。
- >65岁者SBE与院内死亡OR 0.62(95%CI 0.45-0.87,P=0.005),预测AUC 0.883(95%CI 0.750-0.951)。
- SBE与入住ICU、急性肾衰竭、急性呼吸衰竭、脓毒症和凝血功能障碍显著相关。
适用人群与场景
- 2021至2022年间连续纳入的151例热射病患者,于急诊科入院时检测SBE。
研究设计与关键结果
- 研究类型为回顾性、观察性多中心队列研究,连续纳入2021至2022年间151例热射病患者,急诊入院时检测SBE,主要终点为院内死亡,次要终点包括急诊使用血管活性药物、入住ICU、急性肾衰竭、急性心力衰竭、急性呼吸衰竭、脓毒症和凝血功能障碍。
- SBE中位数-4.70(-8.05至-1.55)mmol/L,院内总死亡率12.58%。
- SBE与院内死亡独立相关:OR 0.81(95%CI 0.70-0.95,P=0.011)。
- 年龄和热射病类型对SBE与院内死亡的关系有交互作用;经典热射病者OR 0.5(95%CI 0.3-0.9,P<0.018),>65岁者OR 0.62(95%CI 0.45-0.87,P=0.005)。
- SBE预测院内死亡的AUC在经典热射病组为0.868(95%CI 0.704-0.962),在>65岁组为0.883(95%CI 0.750-0.951)。
- SBE与入住ICU、急性肾衰竭、急性呼吸衰竭、脓毒症和凝血功能障碍显著相关。
证据类型、等级与局限
- 证据类型:回顾性、观察性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急诊入院的热射病患者,检测SBE有助于识别院内死亡及入住ICU、急性肾衰竭、急性呼吸衰竭、脓毒症、凝血功能障碍等不良结局风险较高者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Standard base excess (SBE) is a quick and effective tool to identify acid-base disorders in critically ill patients, independent of respiratory factors. The predictive value of SBE for adverse outcomes in patients with heat stroke (HS) is still unclear. This study aimed to explore the prognostic significance of SBE for in-hospital mortality and other adverse outcomes in patients with HS.
METHODS: A retrospective, observational multicenter cohort study with consecutive patients between 2021 and 2022 was conducted. The SBE was performed upon emergency department (ED) admission. The primary outcome was in-hospital mortality. Secondary outcomes included the use of vasoactive drugs in the ED, admission to the ICU, acute kidney failure, acute heart failure, acute respiratory failure, sepsis, and coagulation impairment. Logistic regression models and receiver operating characteristic (ROC) curves were used to estimate the association of SBE with outcomes in HS patients. Interaction and stratified analyses were also conducted.
RESULTS: The median level of SBE was -4.70 (-8.05- -1.55) mmol/L. Overall hospital mortality in these 151 HS patients was 12.58%. SBE was independently associated with hospital mortality (OR 0.81, 95% CI 0.70-0.95, P = 0.011). Age and HS type played interactive roles in the relationship between SBE and in-hospital mortality. The OR between SBE and hospital mortality was 0.5 (95% CI, 0.3-0.9; p < 0.018) in classic HS participants and 0.62 (95% CI, 0.45-0.87; p = 0.005) in participants aged >65 years. The AUC of SBE to predict in-hospital mortality was 0.868 (95% CI: 0.704-0.962) and 0.883 (95% CI: 0.750-0.951) in these two groups, respectively. SBE was significantly associated with admission to the ICU, acute kidney failure, acute respiratory failure, sepsis, and coagulation impairment.
CONCLUSION: SBE upon emergency admission was significantly associated with adverse outcomes in patients with HS.
参考来源
- Chen L, Yang X, Zhao J, et al. The association of standard base excess upon emergency admission with outcomes in patients with heat stroke. Am J Emerg Med. 2023. PMID: 37451066. doi:10.1016/j.ajem.2023.06.048
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。